Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

0RC6

Pharma Mar (0RC6)

Pharma Mar Sa
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0RC6
DateTimeSourceHeadlineSymbolCompany
01/11/20228:13AMPR Newswire (US)Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variantsLSE:0RC6Pharma Mar Sa
01/11/20228:09AMPR Newswire (US)Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variantsLSE:0RC6Pharma Mar Sa
12/22/20214:17AMPR Newswire (US)PharmaMar signs a new licensing and commercialization agreement with Eczacibasi for lurbinectedin in TurkeyLSE:0RC6Pharma Mar Sa
12/13/20217:39AMPR Newswire (US)PharmaMar and Jazz Pharmaceuticals announce initiation of confirmatory phase III clinical trial of Zepzelca® (lurbinectedin) for the treatment of patients with relapsed Small Cell Lung CancerLSE:0RC6Pharma Mar Sa
11/11/20216:39AMPR Newswire (US)PharmaMar signs a licensing and commercialization agreement with Lotus Pharmaceutical for lurbinectedin in TaiwanLSE:0RC6Pharma Mar Sa
04/28/20205:39AMPR Newswire (US)PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitid...LSE:0RC6Pharma Mar Sa
04/28/20205:35AMPR Newswire (US)PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitid...LSE:0RC6Pharma Mar Sa
 Showing the most relevant articles for your search:LSE:0RC6